Hepatitis B virus reactivation during direct‐acting antiviral treatment of chronic hepatitis C: A hidden danger of an otherwise major success story

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Hepatology

• Publication date

  2017-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.29185PMID 28370190
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AASLD/IDSA HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

  2018cited by this paper
• Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals

  2017influential reference
• EASL Recommendations on Treatment of Hepatitis C 2016.

  2017cited by this paper
• Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct‐acting Antiviral Agents

  2017cited by this paper
• Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta‐analysis

  2017influential reference
• No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.

  2016cited by this paper
• DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment

  2016cited by this paper
• Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

  2015cited by this paper
• Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir.

  2015cited by this paper
• Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.

  2015cited by this paper
• Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.

  2014cited by this paper
• Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: Prevalence, racial/ethnic differences, and viral interactions

  2010cited by this paper
• European Association for the Study of the Liver

  2006cited by this paper
• Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus–coinfected patients

  2006cited by this paper
• Mechanisms for Inhibition of Hepatitis B Virus Gene Expression and Replication by Hepatitis C Virus Core Protein*

  2003cited by this paper
• Coinfection of hepatitis C virus in patients with chronic hepatitis B infection.

  1994cited by this paper

• A DESCRIPTIVE STUDY TO ASSESS THE KNOWLEDGE AND ATTITUDE OF STAFF NURSES REGARDING PREVENTION OF HEPATITIS –B

  2022cites this paper
• An update on direct antiviral agents for the treatment of hepatitis C

  2021cites this paper
• Serology of hepatitis B virus : multiple scenarios and multiple exams

  2019cites this paper
• Treatment of hepatitis C: the use of the new pangenotypic direct‐acting antivirals in “special populations”

  2018cites this paper
• Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies.

  2018cites this paper
• Serología del virus de la hepatitis B: para múltiples escenarios, múltiples exámenes

  2018cites this paper
• Hepatitis C: from discovery to cure

  2018cites this paper
• Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct‐acting antiviral therapy

  2018cites this paper
• Late hepatitis B reactivation following direct‐acting antiviral–based treatment of recurrent hepatitis C in an anti‐HBc–positive liver transplant recipient

  2018cites this paper
• An update on the treatment options for HBV/HCV coinfection

  2017cites this paper